Copper Rock Capital Partners’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Copper Rock Capital Partners’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-12,600	Closed	-$424K	–	62
2014 Q4	$424K	Sell	12,600 -1,429	-10%	-$50.5K	0.04%	50
2014 Q3	$491K	Buy	14,029 +587	+4%	+$20.1K	0.05%	51
2014 Q2	$442K	Sell	13,442 -358	-3%	-$12.3K	0.07%	46
2014 Q1	$509K	Sell	13,800 -300	-2%	-$11K	0.05%	157
2013 Q4	$541K	Buy	14,100 +11,100	+370%	+$350K	0.05%	169
2013 Q3	$82K	Sell	3,000 -600	-17%	-$14.2K	0.01%	181
2013 Q2	$76K	Buy	+3,600	New	+$70.3K	0.01%	176

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Copper Rock Capital Partners's WX Position: Q1 2015 in Review

Copper Rock Capital Partners sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q1 2015, closing a stake of 12,600 shares — an estimated $424K sold.

Copper Rock Capital Partners first reported a position in WX in Q2 2013 and held it in 7 quarters. The position peaked at $541K in Q4 2013. 147 funds tracked by Wall St. Rank hold WX as of Q1 2015.

Copper Rock Capital Partners reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q1 2015 after selling out during the quarter.
Copper Rock Capital Partners sold 12,600 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q1 2015, an estimated $424K.
Copper Rock Capital Partners first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 7 quarters.
Copper Rock Capital Partners's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $541K in Q4 2013.
147 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q1 2015.

Based on Copper Rock Capital Partners's 13F filing for Q1 2015, filed 9 Apr 2015.